Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety and quality of life
in patients with primary cutaneous T-cell lymphomas after failure of topical or phototherapy
treatment.